Boostrix, Adacel Get Advisory Cmte. Backing, But Postmarket Studies Urged

Postmarketing studies are needed to monitor the safety and effectiveness of GlaxoSmithKline's Boostrix and Sanofi Pasteur's Adacel in individuals who will receive only acellular primary pertussis vaccine, FDA's Vaccines & Related Blood Products Advisory Committee said March 15